IP Library Assignment 057596/0832
Patent Assignment
Reel/Frame 057596/0832

Assignment of Assignor's Interest

Recorded: 2021-09-23 Pages: 23
Assignor
FORMA THERAPEUTICS, INC.
Executed: 2020-04-30
Assignee
INTEGRAL EARLY DISCOVERY, INC.
399 BOYLSTON STREET, BOSTON, MASSACHUSETTS, 02116
Covered Property (1)
Pyrrolotriazinones and Imidazotriazinones as Ubiquitin-Specific Protease 7 Inhibitors
Application: 17/230,603 →
Publication: US 2022/0033403
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 21, 2021
From: IOANNIDIS, STEPHANOS; TALBOT, ADAM CHARLES; FOLLOWS, BRUCE; BUCKMELTER, ALEXANDRE JOSEPH
To: FORMA THERAPEUTICS, INC.
Reel/Frame 056937/0106 →
Change of Name Jul 21, 2021
From: INTEGRAL EARLY DISCOVERY, INC.
To: VALO EARLY DISCOVERY, INC.
Reel/Frame 056940/0570 →
Merger Sep 8, 2021
From: VALO EARLY DISCOVERY, INC.
To: VALO HEALTH, INC.
Reel/Frame 057438/0025 →
Security Interest Jul 6, 2023
From: VALO HEALTH, LLC; VALO HEALTH, INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY, AS AGENT
Reel/Frame 064207/0957 →
Release of Security Interest Oct 17, 2023
From: FIRST-CITIZENS BANK & TRUST COMPANY, AS AGENT
To: VALO HEALTH, INC.; VALO HEALTH, LLC
Reel/Frame 065255/0660 →